The Ankylosing Spondylitis Disease Activity Score (ASDAS-CRP) well reflected for evaluating quality of life and function; however, the modest correlation observed between disease activity and spinal mobility indicates that insufficient treatment may not effectively prevent structural damage. This evidence concerns the gene CRP and ankylosing spondylitis.